Mridul Agrawal, Managing Director and Co-Founder at iuvando Health, shared a post on LinkedIn:
“I’m excited to announce a new partnership between the German Ovarian Cancer Foundation (Deutsche Stiftung Eierstockkrebs) and iuvando Health.
The collaboration is driven by a shared goal: making it easier for women with gynecological cancers and breast cancer to learn about and access relevant clinical trials. Clinical research continues to drive some of the most important advances in oncology. Yet, too many patients still face significant challenges when it comes to identifying suitable studies and navigating the clinical trial landscape.
By combining the German Ovarian Cancer Foundation‘s trusted patient education platform with iuvando’s physician-led clinical trial matching approach, we are actively working to help more patients access innovative treatment opportunities and make informed decisions about their care.
I’m particularly grateful to Prof. Dr. Jalid Sehouli (Charité – Universitätsmedizin Berlin), Susanne Fechner (Deutsche Stiftung Eierstockkrebs) and Rosa K. (Deutsche Stiftung Eierstockkrebs) for their trust, collaboration and longstanding commitment to improving outcomes for women and their families affected by cancer. It is a privilege to work together on a mission that matters deeply to all of us.
Really looking forward to the impact we can create together.”
Other articles on OncoDaily.